Patents by Inventor Robert Preston

Robert Preston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11668845
    Abstract: A wide band gap semiconductor NAND based neutron detection system includes a semiconductor layer comprising a wide band gap material with a neutron absorber material in the wide band gap material, and the semiconductor layer is the only layer of the wide band gap semiconductor NAND based neutron detection system fabricated with the neutron absorber material.
    Type: Grant
    Filed: July 8, 2021
    Date of Patent: June 6, 2023
    Assignee: Consolidated Nuclear Security, LLC
    Inventors: Jeffrey Robert Preston, Ashley C. Stowe
  • Patent number: 11612528
    Abstract: Various implementations include neonatal transport apparatuses and systems employing such apparatuses. In one particular implementation, an apparatus includes: an isolation stage; a first mount on a first portion of the isolation stage, the first mount configured to engage a mounting frame of a neonatal transport unit; a second mount on a second portion of the isolation stage, the second mount configured to engage a stretcher; and a stabilizing coupler extending from the second portion of the isolation stage, the stabilizing coupler positioned to directly couple the isolation stage with a floor underlying the stretcher.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: March 28, 2023
    Assignee: Children's Health Care
    Inventor: Robert Preston Parker
  • Patent number: 11576902
    Abstract: The treatment of human subjects suffering from COVID-19 comprises the step of administering to the human subjects a medicament selected from the group consisting of 1,3-bis(7-methoxy-4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)propane, and/or the isomers, tautomers, enantiomers, esters, derivatives, metal complexes, prodrugs, solvates, metabolites, and pharmaceutically acceptable salts thereof. The medicament may also be contacted with SARS-CoV-2 virus for inhibition of the virus.
    Type: Grant
    Filed: December 1, 2020
    Date of Patent: February 14, 2023
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Robert Preston Moore, Cameron E. West, Jason H. West, Krishna Mohan Donavalli
  • Publication number: 20230019822
    Abstract: A wide band gap semiconductor NAND based neutron detection system includes a semiconductor layer comprising a wide band gap material with a neutron absorber material in the wide band gap material, and the semiconductor layer is the only layer of the wide band gap semiconductor NAND based neutron detection system fabricated with the neutron absorber material.
    Type: Application
    Filed: July 8, 2021
    Publication date: January 19, 2023
    Inventors: Jeffrey Robert PRESTON, Ashley C. STOWE
  • Publication number: 20230000795
    Abstract: Multiple active component therapeutic formulations are described comprising at least two active agents selected from the group consisting of an isovanillin component, a harmine component, and a curcumin component, stabilized in a self-supporting lipid crystalline formulation for topical application. The formulation maintains the active agents in a stable form during storage and will melt at body temperature when applied to the skin, wherein the lipid crystals melt into a liquid crystalline structure thereby releasing the active agents to the applied area of the skin or tissue to render their therapeutic effect.
    Type: Application
    Filed: June 10, 2022
    Publication date: January 5, 2023
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Åke Richard Lindal, Anette Susanne Nilsson, Cameron E. West, Stefan Proniuk, Robert Preston Moore
  • Patent number: 11484492
    Abstract: Topical medicaments for the treatment of mammalian skin are provided, which include an actives fraction and a carrier fraction; the actives fraction comprises individual amounts of turmeric, Peganum harmala, and Arum palaestinum. In other embodiments, the actives fraction includes additional ingredients, including Vitamin C, ?-sitosterol, and vanillin compound(s). The medicaments are useful in the treatment of a wide variety of conditions.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: November 1, 2022
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Rachel Elizabeth Ropp
  • Patent number: 11391851
    Abstract: Techniques are disclosed for systems and methods to provide a radiation detector module for a radiation detector. A radiation detector module includes a metallic and/or metalized enclosure, a radiation sensor disposed within the enclosure, readout electronics configured to provide radiation detection event signals corresponding to incident ionizing radiation in the radiation sensor, and a cap including an internal interface configured to couple to the readout electronics and an external interface configured to couple to a radiation detector, where the cap is configured to hermetically seal the radiation sensor within the enclosure. The cap may be implemented as an edge plated printed circuit board (PCB) including a slot configured to mate with a planar edge of an open surface of the enclosure, where the slot is soldered to the planar edge of the enclosure to hermetically seal the radiation sensor within the enclosure.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: July 19, 2022
    Assignee: Teledyne FLIR Detection, Inc.
    Inventors: Hartmut Brands, Stephen W. Fleetwood, Leslie D. Hoy, Jason K. Smith, Felix J. Liang, Matthew D. Waggoner, Kyle Hawes, Jeffrey Robert Preston, Jeffrey A. Verity
  • Publication number: 20220193007
    Abstract: The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a multiple-component antiviral formulation comprising a curcumin component, harmine component, and isovanillin component, and/or variants thereof. The formulation may also be used to inhibit SARS-CoV-2 virus in cell-based assays or in the manufacture of antiviral medicaments.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 23, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Cameron E. West, Robert Preston Moore, Jason H. West
  • Publication number: 20220175868
    Abstract: The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a formulation comprising Arum spp., particularly Arum palaestinum. Methods of inhibiting SARS-CoV-2 viral replication are also disclosed comprising contacting the virus with an Arum formulation.
    Type: Application
    Filed: December 2, 2021
    Publication date: June 9, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Larry D. Crow, Jason H. West
  • Publication number: 20220175869
    Abstract: The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a formulation comprising turmeric, Peganum harmala, and Arum palaestinum, and/or variants thereof. Methods of inhibiting SARS-CoV-2 viral replication are also described.
    Type: Application
    Filed: December 2, 2021
    Publication date: June 9, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Larry D. Crow, Jason H. West
  • Publication number: 20220175769
    Abstract: Novel medicaments for the treatment of actinic keratoses are provided, along with methods of treatment. The medicaments include respective quantities of curcumin, harmine, and isovanillin, which can be used alone or in combination with fluorouracil. In the latter cases, the three-component compositions provide a synergistic or adjuvant effect with fluorouracil.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 9, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Cameron E. West, Robert Preston Moore, Paul Dent, Shawn G. Kwatra
  • Patent number: 11353084
    Abstract: An active vibration isolation system for isolating a suspended platform from vibration input to the vibration isolation system base includes an exoskeleton, a rotary actuator, and a drive mechanism separate from the exoskeleton for providing force output from the rotary actuator to the suspended plant. The rotary actuator may include inner and outer rotors which rotate relative to each other. The rotary actuator may be free to translate relative to the vibration isolation system base and the suspended platform, and both the inner and outer rotors may be free to rotate relative to the exoskeleton.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 7, 2022
    Assignee: ClearMotion Acquisition I LLC
    Inventors: Thomas C. Schroeder, Robert Preston Parker, Dariusz Antoni Bushko, Brian A. Selden, Mark A. Hayner, Brian M. Lucas
  • Publication number: 20220168282
    Abstract: The treatment of human subjects suffering from COVID-19 comprises the step of administering to the human subjects a medicament selected from the group consisting of 1,3-bis(7-methoxy-4,9-dihydro-3H-pyrido[3,4-b]indol-1-yl)propane, and/or the isomers, tautomers, enantiomers, esters, derivatives, metal complexes, prodrugs, solvates, metabolites, and pharmaceutically acceptable salts thereof. The medicament may also be contacted with SARS-CoV-2 virus for inhibition of the virus.
    Type: Application
    Filed: December 1, 2020
    Publication date: June 2, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Robert Preston Moore, Cameron E. West, Jason H. West, Krishna Mohan Donavalli
  • Patent number: 11310587
    Abstract: A loudspeaker includes a first electro-acoustic transducer, a horn acoustically coupled to the first electro-acoustic transducer, and a first acoustic leak that is acoustically coupled to the horn. The first acoustic leak is positioned so as to reduce a peak in a frequency response of the loudspeaker at the targeted frequency without removing the targeted frequency from the output of the loudspeaker.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: April 19, 2022
    Assignee: Bose Corporation
    Inventors: David Edwards Blore, Randy J. Kulchy, Robert Preston Parker
  • Patent number: 11275471
    Abstract: Various aspects include audio devices with a capacitive sensing interface along a compound curved wall. Some aspects of the disclosure relate to wearable audio devices with a capacitive sensing interface and a flexible printed circuit board (PCB) for detecting a touch command at the interface. In certain cases, the flexible PCB has at least one slit for conforming to the compound curve of the wall. In additional implementations, the inner surface of the wall is faceted and the flexible PCB conforms to the facets in the wall.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: March 15, 2022
    Assignee: BOSE CORPORATION
    Inventors: Robert Preston Parker, Thomas Aquinas Nilsen
  • Patent number: 11246902
    Abstract: Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: February 15, 2022
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow, Robert Preston Moore, Rachel Elizabeth Ropp
  • Publication number: 20220008359
    Abstract: Combination dosage forms of anti-cancer products include components a) and b), where component a) comprises individual amounts of curcumin, harmine, isovanillin, and component b) comprises an agent selected from the group consisting of EGFR inhibitors, CDK 4/6 inhibitors, 5-fluorouracil, checkpoint inhibitors, anti-metabolites, prodrugs thereof, and mixtures thereof. The products may be administered to mammalian subjects suffering from a variety of cancers, to provide a synergistic therapeutic effect.
    Type: Application
    Filed: July 8, 2021
    Publication date: January 13, 2022
    Inventors: Gene H. Zaid, Cameron E. West, Robert Preston Moore, Paul Dent
  • Publication number: 20220004272
    Abstract: Various aspects include audio devices with a capacitive sensing interface along a compound curved wall. Some aspects of the disclosure relate to wearable audio devices with a capacitive sensing interface and a flexible printed circuit board (PCB) for detecting a touch command at the interface. In certain cases, the flexible PCB has at least one slit for conforming to the compound curve of the wall. In additional implementations, the inner surface of the wall is faceted and the flexible PCB conforms to the facets in the wall.
    Type: Application
    Filed: July 2, 2020
    Publication date: January 6, 2022
    Inventors: Robert Preston Parker, Thomas Aquinas Nilsen
  • Publication number: 20210105557
    Abstract: A loudspeaker includes a first electro-acoustic transducer, a horn acoustically coupled to the first electro-acoustic transducer, and a first acoustic leak that is acoustically coupled to the horn. The first acoustic leak is positioned so as to reduce a peak in a frequency response of the loudspeaker at the targeted frequency without removing the targeted frequency from the output of the loudspeaker.
    Type: Application
    Filed: October 8, 2019
    Publication date: April 8, 2021
    Inventors: David Edwards Blore, Randy J. Kulchy, Robert Preston Parker
  • Publication number: 20210096270
    Abstract: Techniques are disclosed for systems and methods to provide a radiation detector module for a radiation detector. A radiation detector module includes a metallic and/or metalized enclosure, a radiation sensor disposed within the enclosure, readout electronics configured to provide radiation detection event signals corresponding to incident ionizing radiation in the radiation sensor, and a cap including an internal interface configured to couple to the readout electronics and an external interface configured to couple to a radiation detector, where the cap is configured to hermetically seal the radiation sensor within the enclosure. The cap may be implemented as an edge plated printed circuit board (PCB) including a slot configured to mate with a planar edge of an open surface of the enclosure, where the slot is soldered to the planar edge of the enclosure to hermetically seal the radiation sensor within the enclosure.
    Type: Application
    Filed: September 11, 2020
    Publication date: April 1, 2021
    Inventors: Hartmut Brands, Stephen W. Fleetwood, Leslie D. Hoy, Jason K. Smith, Felix J. Liang, Matthew D. Waggoner, Kyle Hawes, Jeffrey Robert Preston, Jeffrey A. Verity